NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet announced a quarterly dividend on Monday, December 16th. Stockholders of record on Friday, December 27th will be given a dividend of $0.24 per share on Friday, January 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, December 26th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) posted its earnings results on Tuesday, November, 5th. The medical equipment provider reported $1.77 EPS for the quarter, topping the consensus estimate of $1.75 by $0.02. The medical equipment provider had revenue of $1.89 billion for the quarter, compared to analysts' expectations of $1.87 billion. Zimmer Biomet had a negative net margin of 1.14% and a positive return on equity of 13.71%. The company's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.63 EPS. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided EPS guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

24 brokers have issued 1 year price objectives for Zimmer Biomet's shares. Their forecasts range from $108.00 to $187.00. On average, they anticipate Zimmer Biomet's stock price to reach $154.57 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 3 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

News articles about ZBH stock have been trending somewhat positive recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Zimmer Biomet earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Walt Disney (DIS), Verizon Communications (VZ), Bristol-Myers Squibb (BMY), Chevron (CVX), Intel (INTC) and Home Depot (HD).

Zimmer Biomet's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.43%), Heritage Investors Management Corp (0.06%), PGGM Investments (0.05%), Birch Hill Investment Advisors LLC (0.04%), Nisa Investment Advisors LLC (0.04%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, OLD National Bancorp IN, Sciencast Management LP, Enterprise Trust & Investment Co, Nisa Investment Advisors LLC, IFM Investors Pty Ltd and Greylin Investment Mangement Inc.. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Red Spruce Capital LLC, Appleton Partners Inc. MA, Harvest Investment Services LLC, Allred Capital Management LLC and First Hawaiian Bank. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $149.38.

Zimmer Biomet has a market capitalization of $30.72 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]